Quasispecies Analysis of SARS-CoV-2 of 15 Different Lineages during the First Year of the Pandemic Prompts Scratching under the Surface of Consensus Genome Sequences.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
10 Dec 2022
Historique:
received: 10 11 2022
revised: 01 12 2022
accepted: 02 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

The tremendous majority of SARS-CoV-2 genomic data so far neglected intra-host genetic diversity. Here, we studied SARS-CoV-2 quasispecies based on data generated by next-generation sequencing (NGS) of complete genomes. SARS-CoV-2 raw NGS data had been generated for nasopharyngeal samples collected between March 2020 and February 2021 by the Illumina technology on a MiSeq instrument, without prior PCR amplification. To analyze viral quasispecies, we designed and implemented an in-house Excel file (“QuasiS”) that can characterize intra-sample nucleotide diversity along the genomes using data of the mapping of NGS reads. We compared intra-sample genetic diversity and global genetic diversity available from Nextstrain. Hierarchical clustering of all samples based on the intra-sample genetic diversity was performed and visualized with the Morpheus web application. NGS mapping data from 110 SARS-CoV-2-positive respiratory samples characterized by a mean depth of 169 NGS reads/nucleotide position and for which consensus genomes that had been obtained were classified into 15 viral lineages were analyzed. Mean intra-sample nucleotide diversity was 0.21 ± 0.65%, and 5357 positions (17.9%) exhibited significant (>4%) diversity, in ≥2 genomes for 1730 (5.8%) of them. ORF10, spike, and N genes had the highest number of positions exhibiting diversity (0.56%, 0.34%, and 0.24%, respectively). Nine hot spots of intra-sample diversity were identified in the SARS-CoV-2 NSP6, NSP12, ORF8, and N genes. Hierarchical clustering delineated a set of six genomes of different lineages characterized by 920 positions exhibiting intra-sample diversity. In addition, 118 nucleotide positions (0.4%) exhibited diversity at both intra- and inter-patient levels. Overall, the present study illustrates that the SARS-CoV-2 consensus genome sequences are only an incomplete and imperfect representation of the entire viral population infecting a patient, and that quasispecies analysis may allow deciphering more accurately the viral evolutionary pathways.

Identifiants

pubmed: 36555300
pii: ijms232415658
doi: 10.3390/ijms232415658
pmc: PMC9779826
pii:
doi:

Substances chimiques

Nucleotides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Agence Nationale de la Recherche
ID : Méditerranée-Infection 10-IAHU-03
Organisme : Région Provence Alpes Côte d'Azur and Europe
ID : FEDER PA 0000320 PRIMMI
Organisme : French Ministry of Higher Education, Research and Innovation
ID : Not applicable
Organisme : French Ministry of Solidarity and Health
ID : Not applicable

Références

Bull World Health Organ. 2020 Jul 01;98(7):495-504
pubmed: 32742035
Microbiol Spectr. 2022 Jun 29;10(3):e0071622
pubmed: 35658573
Circulation. 2019 Oct 29;140(18):1506-1518
pubmed: 31657957
J Virol. 2005 Jul;79(13):8249-61
pubmed: 15956571
Microbiol Spectr. 2021 Sep 3;9(1):e0026121
pubmed: 34346744
Travel Med Infect Dis. 2021 Mar-Apr;40:101980
pubmed: 33535105
Cell Host Microbe. 2021 Jul 14;29(7):1124-1136.e11
pubmed: 34171266
Viruses. 2022 Jul 27;14(8):
pubmed: 36016262
J Med Virol. 2022 Aug;94(8):3739-3749
pubmed: 35467028
Virol J. 2004 Dec 09;1:13
pubmed: 15588294
Gene. 1976;1(1):3-25
pubmed: 1052322
Viruses. 2021 Jan 19;13(1):
pubmed: 33477885
Clin Microbiol Infect. 2022 Jan;28(1):139.e5-139.e8
pubmed: 34537363
Cell. 2021 Sep 30;184(20):5179-5188.e8
pubmed: 34499854
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):
pubmed: 34292871
J Med Virol. 2022 Nov;94(11):5174-5188
pubmed: 35765167
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Nat Commun. 2021 Nov 16;12(1):6612
pubmed: 34785663
FASEB J. 1996 Jun;10(8):859-64
pubmed: 8666162
Mol Biol Evol. 2022 Feb 3;39(2):
pubmed: 35106601
Biochem Biophys Res Commun. 2021 Jan 29;538:116-124
pubmed: 33685621
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Bioinformatics. 2022 Mar 4;38(6):1735-1737
pubmed: 34954792
Virology. 2015 May;479-480:46-51
pubmed: 25824477
Cell Rep Med. 2023 Feb 21;4(2):100943
pubmed: 36791724
Emerg Microbes Infect. 2020 Dec;9(1):1900-1911
pubmed: 32752979
Virology. 2000 May 10;270(2):310-6
pubmed: 10792990
Sci Adv. 2021 Apr 16;7(16):
pubmed: 33863729
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
Genome Med. 2021 Feb 22;13(1):30
pubmed: 33618765
Virulence. 2021 Dec;12(1):1209-1226
pubmed: 34030593
J Infect. 2022 May;84(5):722-746
pubmed: 35041922
PLoS Pathog. 2010 Jul 22;6(7):e1001005
pubmed: 20661479
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1059-65
pubmed: 15306390
Virology. 2022 Jul;572:44-54
pubmed: 35580380
J Med Virol. 2022 Jan;94(1):310-317
pubmed: 34506640
Microbiol Mol Biol Rev. 2012 Jun;76(2):159-216
pubmed: 22688811
Nat Commun. 2020 Nov 25;11(1):5986
pubmed: 33239633
Int J Infect Dis. 2021 May;106:228-236
pubmed: 33785459
Int J Mol Sci. 2022 May 29;23(11):
pubmed: 35682761
Microbiol Spectr. 2021 Dec 22;9(3):e0180321
pubmed: 34878296
Nucleic Acids Res. 2022 Jan 7;50(D1):D161-D164
pubmed: 34850943
Pathogens. 2020 Mar 20;9(3):
pubmed: 32245083
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Trends Microbiol. 1996 Jun;4(6):216-8
pubmed: 8795155
Nature. 2021 Dec;600(7889):408-418
pubmed: 34880490
mBio. 2022 Apr 26;13(2):e0297921
pubmed: 35352979
PLoS One. 2020 Sep 18;15(9):e0239403
pubmed: 32946527
Int J Infect Dis. 2022 Sep;122:444-448
pubmed: 35724829
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
iScience. 2022 Jan 21;25(1):103589
pubmed: 34909610
Mol Biol Evol. 2021 Jan 23;38(2):702-715
pubmed: 32941612
Q Rev Biophys. 1971 Aug;4(2):149-212
pubmed: 5134461
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Front Microbiol. 2022 Feb 07;12:786233
pubmed: 35197938
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Nat Commun. 2021 Oct 1;12(1):5769
pubmed: 34599175

Auteurs

Wahiba Bader (W)

IHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Microbes Evolution Phylogeny and Infections (MEPHI), Institut de Recherche pour le Développement (IRD), Aix-Marseille University, 27 Boulevard Jean Moulin, 13005 Marseille, France.

Jeremy Delerce (J)

IHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.

Sarah Aherfi (S)

IHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Microbes Evolution Phylogeny and Infections (MEPHI), Institut de Recherche pour le Développement (IRD), Aix-Marseille University, 27 Boulevard Jean Moulin, 13005 Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), 264 rue Saint-Pierre, 13005 Marseille, France.

Bernard La Scola (B)

IHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Microbes Evolution Phylogeny and Infections (MEPHI), Institut de Recherche pour le Développement (IRD), Aix-Marseille University, 27 Boulevard Jean Moulin, 13005 Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), 264 rue Saint-Pierre, 13005 Marseille, France.

Philippe Colson (P)

IHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Microbes Evolution Phylogeny and Infections (MEPHI), Institut de Recherche pour le Développement (IRD), Aix-Marseille University, 27 Boulevard Jean Moulin, 13005 Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), 264 rue Saint-Pierre, 13005 Marseille, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH